Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy.
about
Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@ast
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@en
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@nl
type
label
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@ast
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@en
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@nl
prefLabel
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@ast
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@en
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@nl
P2093
P2860
P1476
Body surface area predicts pla ...... intraperitoneal chemotherapy.
@en
P2093
Gleneara E Bates
John A Chabot
John D Allendorf
Joshua C Leinwand
Robert N Taub
Sharyn N Lewin
P2860
P2888
P304
P356
10.1245/S10434-012-2790-8
P577
2013-03-02T00:00:00Z
P5875
P6179
1028600750